Comparison of [18F]Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced Ultrasound for Evaluation of Hepatic Alveolar Echinococcosis Activity

Ultrasound Med Biol. 2018 Nov;44(11):2199-2208. doi: 10.1016/j.ultrasmedbio.2018.06.010. Epub 2018 Aug 2.

Abstract

The mean gray-scale ratio of the infiltrating zone of a lesion to the surrounding normal liver tissue was evaluated on the basis of contrast enhancement of the infiltration and proliferation zones of a hepatic alveolar echinococcosis lesion. The results were compared with the maximum standardized uptake value (SUVmax) of [18F]fluorodeoxyglucose positron emission tomography/computed tomography ([18F]FDG PET-CT), and the application of contrast-enhanced ultrasound in evaluating hepatic alveolar echinococcosis activity is discussed. The 36 patients with hepatic alveolar echinococcosis recruited underwent contrast-enhanced ultrasound and [18F]FDG PET-CT. A total of 39 lesions were found in the 36 patients. The results indicated that in 87.2% of the cases, the two methods yielded the same diagnosis, whereas in 12.8% of cases, the diagnoses obtained with the two methods were inconsistent. The statistical results revealed that contrast-enhanced ultrasound and [18F]FDG PET-CT have good inter-rater reliability in determining the activity of hepatic alveolar echinococcosis (κ = 0.756, p < 0.01).

Keywords: Contrast-enhanced ultrasound; Hepatic alveolar echinococcosis; Lesion activity; Sonovue; [(18)F]Fluorodeoxyglucose positron emission tomography/computed tomography.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Contrast Media*
  • Echinococcosis, Hepatic / diagnostic imaging*
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Image Enhancement / methods*
  • Liver / diagnostic imaging
  • Liver / microbiology
  • Male
  • Middle Aged
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Ultrasonography / methods
  • Young Adult

Substances

  • Contrast Media
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18